- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aker Biomarine AS (AKBMNOK)
Aker Biomarine AS stock price live, this page displays OL AKBM stock exchange data. View the AKBM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aker Biomarine AS real time stock price chart below.
What Is the Aker Biomarine AS Stock Price Today?
The Aker Biomarine AS stock price today is 76.50.
What Is the Stock Symbol for Aker Biomarine AS?
The stock symbol for Aker Biomarine AS is ""AKBM.""
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Oslo stock exchange.
Is Aker Biomarine AS a Good Stock to Buy?
Determining whether Aker Biomarine AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AKBM quote. (ISIN: NO0010886625)
What Is the Aker Biomarine AS Stock Price Today?
The Aker Biomarine AS stock price today is 76.50.
What Is the Stock Symbol for Aker Biomarine AS?
The stock symbol for Aker Biomarine AS is ""AKBM.""
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Oslo stock exchange.
Is Aker Biomarine AS a Good Stock to Buy?
Determining whether Aker Biomarine AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AKBM quote. (ISIN: NO0010886625)
76.50
0.00(0.00%)
Closed·
Fair Value
An estimate of a Aker Biomarine AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.50
76.50
52 wk Range
44.60
104.00
AKBMNOK is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Aker Biomarine AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.5076.50
52 wk Range
44.60104.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AKBMNOK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aker Biomarine AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Aker Biomarine AS Company Profile
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. The Consumer Health Products segment sells processed and packaged krill, fish, and plants derived raw materials to retailers in the United States. The Emerging Business segment offers krill oil under Kori brand name. The company provides protein solutions under the Understory brand; biostimulants under KRBNX brand; and a therapeutic candidate based on omega-3 to manage and treat cardiometabolic diseases under CaPre brand name, as well as delivers circular products utilizing recycled industrial and marine plastic waste under AION name. Aker BioMarine ASA was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Compare AKBMNOK to Peers and Sector
Metrics to compare | AKBMNOK | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipAKBMNOKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 7.0x | 12.2x | |
PEG Ratio | 0.00 | 0.00 | 0.03 | |
Price/Book | 0.0x | 1.6x | 1.5x | |
Price / LTM Sales | 0.0x | 1.0x | 0.9x | |
Upside (Analyst Target) | 0.0% | 113,686.6% | 17.1% | |
Fair Value Upside | Unlock | 9.2% | 10.3% | Unlock |
FAQ
What Stock Exchange Does Aker Biomarine AS Trade On?
Aker Biomarine AS is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Aker Biomarine AS?
The stock symbol for Aker Biomarine AS is "AKBMNOK."
What Is the Aker Biomarine AS Market Cap?
As of today, Aker Biomarine AS market cap is 7.24B.
What Is Aker Biomarine AS's Earnings Per Share (TTM)?
The Aker Biomarine AS EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is AKBMNOK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Aker Biomarine AS Stock Split?
Aker Biomarine AS has split 0 times.
What is the current trading status of Aker Biomarine AS (AKBMNOK)?
As of 23 Jul 2025, Aker Biomarine AS (AKBMNOK) is trading at a price of 76.50, with a previous close of 76.50. The stock has fluctuated within a day range of 76.50 to 76.50, while its 52-week range spans from 44.60 to 104.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.